IDENIX PHARMACEUTICALS INC
IDIX
IDIX was delisted on the 5th of August, 2014.
88 hedge funds and large institutions have $628M invested in IDENIX PHARMACEUTICALS INC in 2013 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 28 increasing their positions, 31 reducing their positions, and 18 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
198% more call options, than puts
Call options by funds: $7.92M | Put options by funds: $2.65M
20% more capital invested
Capital invested by funds: $521M → $628M (+$106M)
10% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 31
5% less funds holding
Funds holding: 93 → 88 (-5)
28% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Baupost Group
Boston,
Massachusetts
|
+$33.5M |
| 2 |
State Street
Boston,
Massachusetts
|
+$2.88M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$2.27M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$2.24M |
| 5 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
+$2.09M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BM
Bridger Management
New York
|
-$9.77M |
| 2 |
Westfield Capital Management
Boston,
Massachusetts
|
-$9.07M |
| 3 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$7.77M |
| 4 |
VAM
Visium Asset Management
New York
|
-$6.81M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.66M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$96K | -18,320 | Closed |
|
|
VKH
102
Virtu KCG Holdings
New York
| – | -$69K | -13,202 | Closed |
|
|
CAM
103
Capstone Asset Management
Houston,
Texas
| – | -$54K | -10,462 | Closed |
|
|
GC
104
Guggenheim Capital
Chicago,
Illinois
| – | -$53K | -10,134 | Closed |
|
|
TRCT
105
Tower Research Capital (TRC)
New York
| – | -$19K | -3,593 | Closed |
|
IDIX Hedge Fund Activity: Q4 2013 in Review
88 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in IDENIX PHARMACEUTICALS INC (IDIX) for Q4 2013, worth a combined $628M — up 20% from $521M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of IDIX and 13 opened new positions — a net loss of 5 holders — while 31 trimmed existing stakes and 28 added.
The largest buyer was Baupost Group, adding an estimated $33.5M. The largest seller was Bridger Management, cutting an estimated $9.77M.
- 88 institutional investors held IDENIX PHARMACEUTICALS INC (IDIX) as of Q4 2013, down from 93 in Q3 2013.
- Funds reported $628M of IDENIX PHARMACEUTICALS INC stock for Q4 2013, up 20% quarter-over-quarter.
- 13 funds opened new IDENIX PHARMACEUTICALS INC positions in Q4 2013 and 18 closed out, a net change of -5 holders.
- The largest IDENIX PHARMACEUTICALS INC buyer in Q4 2013 was Baupost Group, an estimated $33.5M added.
- The largest IDENIX PHARMACEUTICALS INC seller in Q4 2013 was Bridger Management, an estimated $9.77M sold.
Based on aggregated 13F filings for Q4 2013.